Back
Bicara Therapeutics Vs. Impinj Industry Stock Comparison
Sell
43
BCAX
Bicara Therapeutics
Last Price:
$13.34
Seasonality Move:
--
Buy
56
PI
Impinj
Last Price:
$108.52
Seasonality Move:
14.66%
Sell
43
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $12.97. The Score for BCAX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
BCAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $12.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCAX is experiencing slight selling pressure.
PI Stock Price Chart
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 48.44 | Sell |
Chaikin Money Flow: | -291117 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.82 - 14.58) | Buy |
Bollinger Bands (100): | (11.54 - 15.96) | Sell |
PI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.42 | Buy |
Relative Strength Index (14 RSI): | 65.44 | Buy |
Chaikin Money Flow: | -245432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (68.5 - 94.96) | Buy |
Bollinger Bands (100): | (81.57 - 136.59) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.53 | Sell |
20-day SMA: | 13.38 | Sell |
50-day SMA: | 13.04 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.3 | Sell |
20-day EMA: | 13.3 | Sell |
50-day EMA: | 13.24 | Sell |
200-day EMA: | 11.69 | Buy |
PI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 97.04 | Buy |
20-day SMA: | 84.75 | Buy |
50-day SMA: | 86.47 | Buy |
200-day SMA: | 147.06 | Sell |
8-day EMA: | 96 | Buy |
20-day EMA: | 89.91 | Buy |
50-day EMA: | 92.57 | Buy |
200-day EMA: | 125.54 | Sell |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.00 per share, and a decrease next year of $0.52 per share.
Impinj Earnings Growth & PI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.55 per share, a decrease this year of $0.46 per share, and an increase next year of $0.89 per share.
Bicara Therapeutics Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Impinj Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |